Doctoral thesis in structure-based drug design in diabetes at the Helmholtz Zentrum München, Munich (Germany)
Job Details
The need for new and more effective drugs for type 2 diabetes is a major health concern. A doctoral thesis project is available at the Institute of Structural Biology. The main objective of this project is to discover new selective compounds targeting proteins relevant in type 2 diabetes using structure-based approaches.
Qualifications
- We are looking for a highly motivated candidate who has interest in protein expression, structural biology (NMR and X-ray crystallography), diabetes and drug design.
- Applicants should have a Diploma or Master’s degree in Biochemistry with an above-average grade, and practical experience in basic methods of molecular biology and protein biochemistry.
- Previous experience in NMR, crystallography or drug design is a plus.
- The candidate must be innovative, highly motivated, and with a strong interest in team work.
- Strong communication and organizational skills are expected.
Inquiries should be addressed to Dr. Ana Messias ([log in to unmask]) or Prof. Michael Sattler ([log in to unmask])
-------------------------------------------------------
Dr. Ana Messias
Helmholtz Zentrum München
Institute of Structural Biology
(Building 43b, room 103)
Ingolstädter Landstr. 1
85764 Neuherberg
Germany
Tel: +49 (0)89 3187- 4706 (office) / - 3732 (lab)
E-mail: [log in to unmask]
-------------------------------------------------------
Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstr. 1
85764 Neuherberg
www.helmholtz-muenchen.de
Aufsichtsratsvorsitzende: MinDir´in Bärbel Brumme-Bothe
Geschäftsführer: Prof. Dr. Günther Wess und Dr. Nikolaus Blum
Registergericht: Amtsgericht München HRB 6466
USt-IdNr: DE 129521671
|